» Articles » PMID: 32712757

Living with Leg Lymphedema: Developing a Novel Model of Quality Lymphedema Care for Cancer Survivors

Overview
Journal J Cancer Surviv
Specialty Oncology
Date 2020 Jul 27
PMID 32712757
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Lower-extremity lymphedema (LEL) is a lifelong consequence of cancer therapy and can lead to serious physical and psychosocial complications for many cancer survivors. However, clinical knowledge and treatment of LEL remain minimal. The purpose of this study was to integrate perspectives of lymphedema patients and healthcare providers (HCPs) on LEL to develop a novel model for quality lymphedema care.

Methods: A mixed-methods approach was implemented. Standardized questionnaires and semi-structured interviews were used to assess psychosocial well-being and experiences of LEL patients. Interviews were also used to evaluate the clinical experiences of HCPs working within tumour groups associated with cancer-related LEL. Thematic analysis was used to analyse qualitative data.

Results: Twenty-two patients and eleven HCPs participated in this study. Patient QOL, generalized anxiety and depressive symptom scores revealed a complex interplay between psychosocial well-being and supportive LEL care after cancer. Three themes emerged from interviews with patients (n = 19) and HCPs (n = 11): level of lymphedema knowledge, effectiveness of rehabilitation oncology services and barriers to care.

Implications For Cancer Survivors: We developed a novel model for quality lymphedema care that emphasizes the importance of continued physical and psychosocial support for LEL patients, while illustrating the importance of HCPs in facilitating a smooth transition for patients to LEL care after cancer treatment.

Citing Articles

The lymphedema patient experience within the healthcare system: a cross-sectional epidemiologic assessment.

Bowman C, Rockson S Sci Rep. 2024; 14(1):12600.

PMID: 38824156 PMC: 11144203. DOI: 10.1038/s41598-024-63145-1.


The Role of Inflammation in Lymphedema: A Narrative Review of Pathogenesis and Opportunities for Therapeutic Intervention.

Bowman C, Rockson S Int J Mol Sci. 2024; 25(7).

PMID: 38612716 PMC: 11011271. DOI: 10.3390/ijms25073907.


Depressive symptoms and their severity in a sample with lymphedema: a case-control investigation.

Monteiro A, de Labra C, Losa-Iglesias M, Dias A, Becerro-de-Bengoa-Vallejo R, Silva-Migueis H Front Psychiatry. 2023; 14:1202940.

PMID: 37476539 PMC: 10354281. DOI: 10.3389/fpsyt.2023.1202940.

References
1.
Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

2.
Howard A, Smillie K, Turnbull K, Zirul C, Munroe D, Ward A . Access to medical and supportive care for rural and remote cancer survivors in northern British Columbia. J Rural Health. 2014; 30(3):311-21. DOI: 10.1111/jrh.12064. View

3.
Butow P, Phillips F, Schweder J, White K, Underhill C, Goldstein D . Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer. 2011; 20(1):1-22. DOI: 10.1007/s00520-011-1270-1. View

4.
Cornelissen A, Kool M, Keuter X, Heuts E, de Grzymala A, van der Hulst R . Quality of Life Questionnaires in Breast Cancer-Related Lymphedema Patients: Review of the Literature. Lymphat Res Biol. 2018; 16(2):134-139. DOI: 10.1089/lrb.2017.0046. View

5.
Armer J, Heckathorn P . Post-breast cancer lymphedema in aging women: self-management and implications for nursing. J Gerontol Nurs. 2005; 31(5):29-39. DOI: 10.3928/0098-9134-20050501-07. View